A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-Risk Human Papillomavirus Vaccine in Women with Low-grade Cervical Lesions.

Karin Hellner, Philippe Simon, Philippe De Sutter, Kadri-Liina Vahula, Paula Briggs, Ülle Kiisla, Michelle Russell, Claire Newton, Kobe Dewilde, Katie Anderson, Jakub Kopycinski, Antonella Vardeu, Charlotte Davis, Sarah Sebastian, Raisha Kennerley